Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

MORPHINE SULFATE

FDA · NDA · 2026-05-29

AgencyFDA
Submission typeNDA
Action date2026-05-29
BrandMORPHINE SULFATE
SponsorFRESENIUS KABI USA
RouteINTRAMUSCULAR, INTRAVENOUS

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:34:17.242Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:MORPHINE SULFATE:2026-05-29

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

MORPHINE SULFATE — approval | AEaH